European Commission approves label expansion of Roche’s
Hemlibra, already approved for severe haemophilia A in the EU, will now also provide an effective and convenient prophylactic treatment option for people......
EfTEN Real Estate Fund III AS unaudited results for 4th
Fund manager's comment on the 2022 financial results In 2022, major changes took place in the European and Baltic commercial real estate market. The......
Sequana Medical announces grant of additional DSR® patent
PRESS RELEASE Ghent, Belgium – 1 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the......
Entrepreneurship and urban research the focus of new centre
The new centre brings together leading scholars and innovators from Canada and India to develop ground-breaking research and innovation to benefit people......
FSIS Recall Release 003-2023 - Conagra Brands - Processing
Washington D.C., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Recall Release CLASS I......
FAMEEX Implements Changes Following Successful Feedback
FAMEEX is undergoing rapid expansion of the user base and is a reliable crypto exchange broker which operates under a policy of transparency and fairness.......
Surge Copper Announces Closing of Private Placement
Vancouver, British Columbia, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Not for distribution to U.S. newswire services or dissemination in the United States ......